Jump to content

Longest Reported Survival Rate For Locally Advanced Lung

Recommended Posts

Cancer Patients, Study Demonstrates

http://www.medicalnewstoday.com/medical ... wsid=24521

16 May 2005

An investigational chemoradiation regimen has achieved the best long-term survival rates yet reported in patients with locally advanced non-small cell lung cancer, according to results of a Phase II Southwest Oncology Group study presented today at the 41st annual meeting of the American Society of Clinical Oncology.

The study, SWOG-9504, evaluated the use of the chemotherapy agent docetaxel (Taxotere) administered after two other chemotherapy drugs - cisplatin and etoposide - plus radiation therapy. Among patients treated with the regimen, 29 percent were still alive after five years versus 17 percent of patients from a previous study, SWOG-9019. Patients in the earlier study received the same chemoradiation without docetaxel. Median survival also increased from 15 months in SWOG-9019 to 26 months in SWOG-9504.

“The long-term survival data are particularly promising because they exceed the results of all other treatment approaches in this group of patients with locally advanced, Stage IIIB disease,â€

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.